NUMG - ETF AI Analysis
Top Page
Nuveen ESG Mid-Cap Growth ETF (NUMG)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Several of the largest positions, such as Ciena, Quanta Services, Comfort Systems, EMCOR Group, and Interactive Brokers, have shown strong gains, helping support the fund’s overall results.
Sector Diversification Within Growth Areas
The ETF spreads its investments across technology, industrials, health care, consumer cyclical, and other sectors, which helps reduce the impact if any one industry struggles.
Moderate Expense Ratio for an ESG Strategy
The fund’s expense ratio is moderate for an ESG-focused, actively designed mid-cap growth ETF, so fees are not excessively high relative to its specialized approach.
Negative Factors
Recent Weak Overall Performance
The ETF’s returns have been weak over the year to date and over the last three months, which may concern investors looking for steady short-term performance.
Concentration in a Handful of Stocks
The top 10 holdings make up a sizable portion of the portfolio, so poor results from just a few companies could noticeably hurt the fund.
Heavy U.S.-Only Exposure
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market’s ups and downs.
NUMG vs. SPDR S&P 500 ETF (SPY)
AUM350.37M
RegionNorth America
Expense Ratio0.31%
Beta1.10
IssuerNuveen
Inception DateDec 13, 2016
Dividend Yield0.01%
Asset ClassEquity
Index TrackedMSCI Nuveen ESG USA Mid Cap Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,646
30 Day Avg. Volume24,484
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.53Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering43
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NUMG Summary
Nuveen ESG Mid-Cap Growth ETF (NUMG) tracks the MSCI Nuveen ESG USA Mid Cap Growth Index, focusing on medium‑sized U.S. companies that are growing quickly and meet environmental, social, and governance (ESG) standards. It holds innovative businesses like Datadog and Idexx Laboratories, with big weights in technology, industrials, and health care. Someone might invest in NUMG to seek long‑term growth while supporting companies that follow more sustainable and responsible practices, and to diversify beyond large, well-known stocks. A key risk is that growth and mid‑cap stocks can be more volatile, so the ETF’s price can rise and fall sharply with the market.
How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.
What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.
NUMG Top 10 Holdings
NUMG leans heavily into U.S. tech and industrial innovators, with Datadog and Keysight helping power the fund thanks to rising momentum in software and testing gear tied to AI and cloud demand. Comfort Systems and EMCOR add a steady industrial backbone, benefiting from robust construction and infrastructure trends. On the flip side, health-focused names like Idexx and Alnylam, along with Axon, have been losing steam, acting as mild brakes on performance. Overall, the ETF is a U.S.-centric, mid-cap growth story with a clear tilt toward tech-driven, ESG-friendly growth leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Datadog | 4.93% | $17.26M | $92.08B | 81.18% | 69 Neutral | |
| Comfort Systems | 3.64% | $12.74M | $58.93B | 214.19% | 80 Outperform | |
| Axon Enterprise | 3.25% | $11.39M | $41.13B | -29.81% | 58 Neutral | |
| Lumentum Holdings | 3.24% | $11.37M | $57.01B | 637.24% | 61 Neutral | |
| eBay | 3.24% | $11.34M | $49.75B | 44.49% | 70 Outperform | |
| Idexx Laboratories | 3.19% | $11.19M | $44.76B | 8.24% | 78 Outperform | |
| Ciena | 3.11% | $10.90M | $53.00B | 343.16% | 70 Outperform | |
| Veeva Systems | 2.68% | $9.40M | $31.74B | -29.75% | 66 Neutral | |
| WW Grainger | 2.67% | $9.36M | $65.86B | 34.14% | 73 Outperform | |
| Alnylam Pharma | 2.62% | $9.20M | $35.71B | -14.93% | 60 Neutral |
NUMG Technical Analysis
Neutral
―
Price Trends
46.17
Positive
44.50
Positive
45.84
Positive
Market Momentum
0.17
Positive
48.92
Neutral
25.13
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 46.40, equal to the 50-day MA of 46.17, and equal to the 200-day MA of 45.84, indicating a neutral trend. The MACD of 0.17 indicates Positive momentum. The RSI at 48.92 is Neutral, neither overbought nor oversold. The STOCH value of 25.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NUMG.
NUMG Peer Comparison
Comparison Results
Performance Comparison
NUMG
Nuveen ESG Mid-Cap Growth ETF
46.28
-2.05
-4.24%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
―
―
―
RFG
Invesco S&P Midcap 400 Pure Growth ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents